Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents

NCT05597163 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

588

Enrollment

OTHER

Sponsor class

Conditions

Myopia, Progressive

Interventions

DRUG: low concentration atropine (0.01%)
DRUG: low concentration atropine (0.025%)
DRUG: low concentration atropine (0.05%)
DRUG: Placebo

Sponsor

Shanghai Eye Disease Prevention and Treatment Center

Collaborators

[object Object]
[object Object]
[object Object]